Aug. 7 at 3:59 PM
$HCTI Q2 earnings report arrives next week, likely 8/13. Looking forward to details re: operational turnaround progress, monetization opportunities of AI offerings especially Purpose Health. Integration updates from recent Datano and Teladyne acquisitions along the lines of what we saw earlier this week will also be most welcome. Been in and out of this company over the past few years and have experienced some nice windfalls. Timing, discipline & position size matter. Shorts tend to overplay their hands creating opportunities along the lines of what we've seen so far this week. I'd like to see a persuasive bearish case regarding this company's future, ideally something that communicates product knowledge and market awareness. Xenophobic -- and sadly sometimes racist -- appeals just don't interest.
